Comprehensive Assessment in a Longitudinal Study on Young Men Who Have Sex With Men Attracting to chemseX
CLYMAX
A Cross-sectional Descriptive Study Using Mixed Method (Qualitative and Quantitative) Data Collection
1 other identifier
observational
60
1 country
1
Brief Summary
The study is a two-phase observational study that assess multiple aspects of study and young men who have sex with men (YMSM). Phase I of the study will be a cross-sectional descriptive study using a mixed methods data collection (focusing on qualitative data collection) to acquire information necessary for developing a more extensive study on the same matter. Phase II of the study will be a prospective cohort study using a quantitative data collection. Findings from phase I will guide the development of phase II which consist of a larger number of YMSM, important baseline and follow-up questionnaires and comorbidities assessments, sexually transmitted infections testing, and integration to care. This protocol exclusively addresses the phase I of the study. Once the phase I findings are finalized, the principal investigator will submit the phase II to the IRB of the Faculty of Medicine, Chulalongkorn University.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 26, 2022
CompletedFirst Posted
Study publicly available on registry
September 29, 2022
CompletedStudy Start
First participant enrolled
February 20, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 20, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2026
CompletedApril 2, 2026
April 1, 2026
3.1 years
September 26, 2022
April 1, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The study will be divided into two phases. The information on the procedures of the phase I single study visit is presented below.
Qualitative data collection The qualitative study component will use semi-structured individual in-depth interviews (IDIs) in Thai conducted in-person at the team community health clinic facilities. All participants will be included in the qualitative data collection - 40 YMSM, all 10 family members or peers of chemsex users, and all 10 clinic staff. Quantitative data collection Demographic information of all participants, the proportion of all eligible participants who agree to participate in the study, and the relationship status between Group 2 and Group 1 participants will be collected.
12 months
Study Arms (1)
Group 1
A: Current chemsex users Men who have sex with men, Aged 16-35 years, Able to communicate in Thai fluently, Current chemsex users. B: Former chemsex users (discontinued ≥90 days) Men who have sex with men, Aged 16-35 years, Able to communicate in Thai fluently, Former chemsex users (discontinued ≥90 days).
Eligibility Criteria
Current chemsex users
You may qualify if:
- Group 1A: Current chemsex users
- Men who have sex with men
- Aged 16-35 years
- Able to communicate in Thai fluently
- Current chemsex users
- Provide informed consent
- Group 1B: Former chemsex users (discontinued ≥90 days)
- Men who have sex with men
- Aged 16-35 years
- Able to communicate in Thai fluently
- Former chemsex users (discontinued ≥90 days)
- Provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Institute of HIV Research and Innovation
Pathum Wan, Bangkok, 10330, Thailand
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 26, 2022
First Posted
September 29, 2022
Study Start
February 20, 2023
Primary Completion
March 20, 2026
Study Completion
March 30, 2026
Last Updated
April 2, 2026
Record last verified: 2026-04